Allergy Therapeutics plc (AIM:AGY)
London
· Delayed Price · Currency is GBP · Price in GBX 11.50
-0.89 (-7.72%)
Mar 9, 2026, 4:35 PM GMT
Allergy Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 12.79 | 12.92 | 14.85 | 20.52 | 40.27 | Upgrade
|
| Cash & Short-Term Investments | 12.79 | 12.92 | 14.85 | 20.52 | 40.27 | Upgrade
|
| Cash Growth | -0.97% | -13.00% | -27.64% | -49.06% | 8.96% | Upgrade
|
| Accounts Receivable | 2.85 | 2.86 | 2.37 | 2.69 | 2.96 | Upgrade
|
| Other Receivables | 3.19 | 3.35 | 2.69 | 3.21 | 1.66 | Upgrade
|
| Receivables | 6.03 | 6.21 | 5.06 | 5.91 | 4.62 | Upgrade
|
| Inventory | 13.92 | 12.74 | 11.59 | 11.41 | 10.84 | Upgrade
|
| Prepaid Expenses | 1.94 | 1.62 | 2.03 | 4.56 | 1.6 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.53 | Upgrade
|
| Total Current Assets | 34.68 | 33.48 | 33.53 | 42.39 | 57.86 | Upgrade
|
| Property, Plant & Equipment | 24.26 | 23.75 | 23.24 | 20.19 | 19.72 | Upgrade
|
| Goodwill | 3.33 | 3.32 | 3.35 | 3.35 | 3.34 | Upgrade
|
| Other Intangible Assets | 0.93 | 1.37 | 1.79 | 1.69 | 1.41 | Upgrade
|
| Long-Term Deferred Tax Assets | 1.51 | 1.58 | - | - | - | Upgrade
|
| Other Long-Term Assets | 2.84 | 2.91 | 4.87 | 5.33 | 5.76 | Upgrade
|
| Total Assets | 67.54 | 66.41 | 66.77 | 72.95 | 88.09 | Upgrade
|
| Accounts Payable | 4.49 | 4.01 | 4.09 | 4.28 | 2.9 | Upgrade
|
| Accrued Expenses | 8.1 | 8.65 | 12.49 | 11.34 | 13.55 | Upgrade
|
| Current Portion of Long-Term Debt | 0.41 | 0.6 | 0.65 | 0.95 | 0.96 | Upgrade
|
| Current Portion of Leases | 1.48 | 1.52 | 1.16 | 1.32 | 0.79 | Upgrade
|
| Current Income Taxes Payable | 0.91 | 1.43 | - | - | - | Upgrade
|
| Other Current Liabilities | 11.81 | 2.59 | 0.18 | 0.16 | 0.03 | Upgrade
|
| Total Current Liabilities | 27.19 | 18.8 | 18.57 | 18.05 | 18.23 | Upgrade
|
| Long-Term Debt | 53.04 | 22.5 | 26.44 | 1.5 | 2.45 | Upgrade
|
| Long-Term Leases | 5.17 | 6.37 | 7.75 | 6.76 | 6.97 | Upgrade
|
| Pension & Post-Retirement Benefits | 8.59 | 8.61 | 7.92 | 8.32 | 11.29 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.07 | 0.06 | 0.45 | 0.41 | 0.41 | Upgrade
|
| Other Long-Term Liabilities | 1.68 | 2.71 | 3.58 | 0.14 | 0.21 | Upgrade
|
| Total Liabilities | 95.74 | 59.05 | 64.7 | 35.18 | 39.55 | Upgrade
|
| Common Stock | 4.77 | 4.77 | 0.68 | 0.64 | 0.64 | Upgrade
|
| Additional Paid-In Capital | 154.64 | 154.64 | 119.03 | 112.58 | 112.58 | Upgrade
|
| Retained Earnings | -235.23 | -195.28 | -161.87 | -118.54 | -107.4 | Upgrade
|
| Comprehensive Income & Other | 47.63 | 43.23 | 44.23 | 43.09 | 42.72 | Upgrade
|
| Shareholders' Equity | -28.19 | 7.36 | 2.07 | 37.77 | 48.54 | Upgrade
|
| Total Liabilities & Equity | 67.54 | 66.41 | 66.77 | 72.95 | 88.09 | Upgrade
|
| Total Debt | 60.09 | 30.99 | 35.99 | 10.53 | 11.17 | Upgrade
|
| Net Cash (Debt) | -47.3 | -18.07 | -21.14 | 9.99 | 29.1 | Upgrade
|
| Net Cash Growth | - | - | - | -65.69% | 17.42% | Upgrade
|
| Net Cash Per Share | -0.01 | -0.00 | -0.03 | 0.02 | 0.04 | Upgrade
|
| Filing Date Shares Outstanding | 4,766 | 4,766 | 679.1 | 644.1 | 641.77 | Upgrade
|
| Total Common Shares Outstanding | 4,766 | 4,766 | 679.1 | 644.1 | 641.77 | Upgrade
|
| Working Capital | 7.49 | 14.68 | 14.96 | 24.34 | 39.63 | Upgrade
|
| Book Value Per Share | -0.01 | 0.00 | 0.00 | 0.06 | 0.08 | Upgrade
|
| Tangible Book Value | -32.45 | 2.67 | -3.07 | 32.73 | 43.78 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | 0.00 | -0.00 | 0.05 | 0.07 | Upgrade
|
| Land | 3.14 | 3.01 | 3.05 | 3.08 | 3.09 | Upgrade
|
| Machinery | 40.29 | 36.96 | 33.68 | 29.66 | 27.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.